β2-Microglobulin, a 12 kDa protein forming part of the class I HLA (histocompatibility locus antigen) major histocompatibility complex, has been used as a prognosis factor for multiple myeloma and as a marker of renal function, and has been shown to be involved in the pathogenesis of dialysis-related amyloidosis. α2-Macroglobulin has the ability to bind a wide range of physiologically important molecules, thereby influencing their metabolic impact. In this study we show by Western blotting analysis that β2-microglobulin binds to α2-macroglobulin in vitro. This binding was confirmed by BIAcore analysis, and was shown by ELISA to be concentration-dependent. The sequences of the binding peptides in the mature β2-microglobulin molecule were identified by Spot multiple peptide synthesis and α2-macroglobulin binding studies. In conclusion, β2-microglobulin interacts specifically with the universal antiprotease a2-macroglobulin. The identification of this interaction brings into question some of the axioms on the metabolism of β2-microglobulin, and may help to explain the clinical findings observed in b2-microglobulin-related diseases.
α2-Macroglobulin, the main serum antiprotease, binds β2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease
- Views Icon Views
- PDF LinkPDF
- Share Icon Share
Annie GOUIN-CHARNET, Daniel LAUNE, Claude GRANIER, Jean-Claude MANI, Bernard PAU, Georges MOURAD, Àngel ARGILÉS; α2-Macroglobulin, the main serum antiprotease, binds β2-microglobulin, the light chain of the class I major histocompatibility complex, which is involved in human disease. Clin Sci (Lond) 1 April 2000; 98 (4): 427–433. doi: https://doi.org/10.1042/cs0980427
Download citation file: